Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism

NCT01446042 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
306
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Acerus Pharmaceuticals Corporation